Project Grant HT94252510725
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$638K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Charlottesville, VA, USA
Similar Awards
The University of Virginia (UVA) received a $847,875 Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award, effective September 1, 2025 through August 31, 2028, will support research targeting Schwann cell-tumor microenvironment interactions in neurofibroma development. The federal grant funding will enable UVA to conduct advanced biomedical research aimed at transforming healthcare for military service members,...
This federal Project Grant award of $1,592,860.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research to transform healthcare for military service members, veterans, and the broader public. The award was granted to the Rector & Visitors of the University of Virginia, a prominent academic research institution, to conduct ultrasensitive proteomics research for type 1 diabetes prediction and treatment efficacy...
The University of Virginia was awarded a $2,728,777 Project Grant by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, awarded on May 1, 2025, will support advanced biomedical research on "Neuroactive Steroid Biosynthesis and Dynamic GABAA Receptor Reconfiguration in Postpartum Depression" over a performance period ending on April 30, 2029. This research aims to transform healthcare for military service...
The U.S. Defense Health Agency (DHA) awarded a $5,540,949 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Rector & Visitors of the University of Virginia (UVA) to conduct focused ultrasound interventions research for the noninvasive treatment of primary and metastatic breast cancers. The 4-year grant, awarded on September 30, 2025, supports UVA's work to develop advanced focused ultrasound technologies for precise, non-surgical cancer therapies....
The University of Virginia received a $921,351 project grant award on September 30, 2023 from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to support research on "APPROACHES TO ENHANCE VACCINE-INDUCED TUMOR-INFILTRATING LYMPHOCYTES (VITILS) IN MELANOMA". This multi-year grant, scheduled for completion on September 29, 2026, aims to advance biomedical research that can transform healthcare for Service Members and the American public. The...
This $693,642 federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) supports research at the University of Virginia to enhance vaccine-induced tumor-infiltrating lymphocytes (VITILS) in melanoma. The 3-year research project aims to develop innovative approaches to boost the effectiveness of cancer immunotherapies by improving the ability of T cells to infiltrate and attack melanoma tumors. Key deliverables will include...
This Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $3,208,546.00 to the Rector & Visitors of the University of Virginia (UVA) to expand the Generalized Blast Exposure Value Tool. The goal is to determine cumulative blast exposure thresholds in military populations. The award period runs from May 15, 2025 to May 14, 2029. UVA, a prominent academic research institution, will leverage its expertise across...
The University of Virginia will receive $748,422 under a three-year Project Grant award from the Department of the Army Medical Command. The award is funded through the Military Medical Research and Development program (CFDA 12.420). The University will quantify the relationship between brain biomechanics and head exposures relevant to warfighters. Insights gained from this research aim to guide the development of future injury prevention technologies. Specifically, the University seeks to...
This $646,252 Project Grant award from the Department of the Army Medical Command's Military Medical Research and Development program (CFDA 12.420) supports research to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution. The primary awardee, Trustees of Boston University, will conduct this advanced biomedical research. The University of Virginia will provide academic and technical resources, including experiments generating and validating...
The Department of Defense's Defense Health Agency awarded Virginia Commonwealth University (VCU) a $568,461 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "READING HISTONE H2A UBIQUITINATION IN THE FUNCTION OF RSF1 IN BREAST CANCERS WITH RSF1 GENE AMPLIFICATION." The grant, effective from March 1, 2024 through February 28, 2027, will fund VCU's research to advance the scientific understanding of breast cancer and develop...